Erste Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Erste Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.3M	Buy	2,968,945 +240,000	+9%	+$4.65M	0.57%	42
2025 Q4	$58.7M	Buy	2,728,945 +43,000	+2%	+$906K	0.49%	51
2025 Q3	$50.6M	Buy	2,685,945 +1,064,530	+66%	+$19M	0.49%	54
2025 Q2	$27.7M	Buy	1,621,415 +560,350	+53%	+$23.9M	0.23%	98
2025 Q1	$62.8M	Buy	1,061,065 +352,817	+50%	+$37.1M	0.81%	31
2024 Q4	$76M	Buy	708,248 +72,183	+11%	+$8.85M	0.93%	22
2024 Q3	$79.4M	Buy	636,065 +114,665	+22%	+$15.9M	0.95%	20
2024 Q2	$82.4M	Sell	521,400 -50,000	-9%	-$6.42M	1.09%	16
2024 Q1	$74M	Sell	571,400 -130,000	-19%	-$15.9M	1.01%	17
2023 Q4	$67.7M	Buy	701,400 +16,000	+2%	+$1.53M	0.99%	20
2023 Q3	$83.2M	Sell	685,400 -35,460	-5%	-$4.01M	1.43%	9
2023 Q2	$82.3M	Buy	720,860 +72,000	+11%	+$9.28M	1.45%	7
2023 Q1	$89.3M	Buy	648,860 +34,460	+6%	+$4.47M	1.71%	4
2022 Q4	$79.5M	Sell	614,400 -57,460	-9%	-$6.66M	1.68%	4
2022 Q3	$74.2M	Sell	671,860 -107,000	-14%	-$10.8M	1.66%	4
2022 Q2	$58.6M	Hold	778,860	–	–	1.3%	7
2022 Q1	$60.9M	Sell	778,860 -82,000	-10%	-$6.28M	1.16%	7
2021 Q4	$78M	Buy	860,860 +7,800	+0.9%	+$667K	1.41%	6
2021 Q3	$78.8M	Buy	853,060 +30,000	+4%	+$2.31M	1.56%	6
2021 Q2	$64M	Buy	823,060 +181,500	+28%	+$13.8M	1.27%	9
2021 Q1	$47.8M	Buy	641,560 +261,250	+69%	+$24.1M	1.17%	16
2020 Q4	$65.3M	Buy	380,310 +7,950	+2%	+$1.18M	1.81%	3
2020 Q3	$52.4M	Sell	372,360 -28,900	-7%	-$4.39M	1.79%	3
2020 Q2	$64.6M	Sell	401,260 -25,000	-6%	-$3.4M	2.58%	3
2020 Q1	$41.8M	Sell	426,260 -144,000	-25%	-$16.5M	2.43%	2
2019 Q4	$73.6M	Buy	570,260 +21,600	+4%	+$2.18M	3.26%	2
2019 Q3	$41.3M	Buy	548,660 +15,440	+3%	+$1.82M	2.2%	2
2019 Q2	$78.6M	Buy	533,220 +10,100	+2%	+$1.23M	4.18%	1
2019 Q1	$62.3M	Buy	523,120 +14,310	+3%	+$1.84M	3.49%	3
2018 Q4	$54.8M	Buy	+508,810	New	+$63.6M	3.69%	2